StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by RelevantStockon Aug 27, 2020 12:51am

159 Views

Post# 31458902

RE:RE:RE:This is almost fun, let us say a prayer...

It was part of a naming convention: BOLTA, BOLTB, BOLTC. Took me a while to realize and see what was there before my eyes : )

User image

Nailbiter1 wrote: Wadja find?

RelevantStock wrote: You guys will not believe it, but I came across the word BOLTA today, in a very different context and meaning. Hahaha this is perfect.